secukinumab
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Palmoplantar psoriasis is a chronic (long term) and difficult‐to‐treat form of psoriasis that affects the palms of the hands and…
LIU, XIN. Extraction and Anti-Bacterial Effects of Edible Brown Algae Extracts. (Under the direction of Dr. Wenqiao Yuan). The…
Secukinumab has been shown to be effective for the treatment of moderate-to-severe plaque psoriasis in hard-to-treat patients who…
Therapy for ankylosing spondylitis (AS) is a challenge for a physician, primarily because of a small number of therapeutic…
We present EULAR sessions on the latest treatments for rheumatic disease with an infliximab biosimilar, certolizumab pegol…
The review discusses the possibility of result-oriented treatment therapeutic strategy (Т2Т) for patients with psoriasis…
PsA patients show sustained improvement at two years with secukinumab, clinical trial shows.
The proportions of patients who achieved ACR20 responses at week 24 were significantly higher in all secukinumab groups than in…
Two studies published in leading medical journals show that secukinumab, a human monoclonal antibody used to treat psoriasis…
ABSTRACT Psoriasis is a chronic, inflammatory, immune-mediated skin disease that affects roughly 2% of adults in the United…